Merck & Co. Stockholders' Equity before Treasury Stock decreased by 5.2% to $109.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $107.74B to $109.63B. Over 5 years (FY 2020 to FY 2025), Stockholders' Equity before Treasury Stock shows an upward trend with a 7.1% CAGR.
other_stockholders_equity_before_treasury_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $89.98B | $93.04B | $95.29B | $97.95B | $100.01B | $101.22B | $102.48B | $103.41B | $95.31B | $98.31B | $95.03B | $97.81B | $100.98B | $102.33B | $104.62B | $107.74B | $109.49B | $113.65B | $115.61B | $109.63B |
| QoQ Change | — | +3.4% | +2.4% | +2.8% | +2.1% | +1.2% | +1.2% | +0.9% | -7.8% | +3.2% | -3.3% | +2.9% | +3.2% | +1.3% | +2.2% | +3.0% | +1.6% | +3.8% | +1.7% | -5.2% |
| YoY Change | — | — | — | — | +11.2% | +8.8% | +7.5% | +5.6% | -4.7% | -2.9% | -7.3% | -5.4% | +6.0% | +4.1% | +10.1% | +10.1% | +8.4% | +11.1% | +10.5% | +1.8% |